The global oral erectile dysfunction therapeutic market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Erectile dysfunction is the inability to maintain a penile erection enough during intercourse. It is one of the most common sexual disorders in males. The oral erectile dysfunction therapeutic market is growing due to the increasing prevalence of high cholesterol, blood pressure, obesity, smoking, and tobacco consumption, as these factors increase the chances of having erectile dysfunction. According to a survey conducted by World Health Organization in December 2019, around 1.3 billion people intakes tobacco globally. The market is also growing due to the rising prevalence of stress and depression among individuals. According to Mental Health Foundation 2018, an estimation of 74% of people globally has felt so stressed they have been overwhelmed or unable to cope. Erectile dysfunction is growing very rapidly in the past few years. According to Massachusetts Male Aging Study, it is estimated that erectile dysfunction affects one-third of the global men population. It also states that some form of erectile dysfunction affects around 52% of men. According to the Journal of Sexual Medicine, it has been found that erectile dysfunction affects about 26% of men under the age of 40.
A full report Oral Erectile Dysfunction Therapeutics Market of is available at: https://orionmarketreports.com/oral-erectile-dysfunction-therapeutics-market/102456/
Market Coverage
- The market number available for – 2022-2028
- Base year- 2021
- Forecast period- 2022-2028
- Segment Covered-
- By Drug Type
- Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
- Competitive Landscape- Petros Pharmaceuticals, Inc., Reddy’s Laboratories Ltd., and Pfizer, Inc., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
- Deviation from the pre-COVID-19 forecast
- Most affected region and segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Oral Erectile Dysfunction Therapeutic Market Report by Segment
By Drug Type
- Sildenafil
- Vardenafil
- Tadalafil
- Avanafil
- Udenafil
- Others
By Application
- Hospitals
- Clinics
- Cancer Research Institutes
Recent Developments
- Market Overview and growth analysis
- Import and Export Overview
- Volume Analysis
- Current Market Trends and Future Outlook
- Market Opportunistic and Attractive Investment Segment
Geographic Coverage
- North America Market Size and/or Volume
- Latin America Market Size and/or Volume
- Europe Market Size and/or Volume
- Asia-Pacific Market Size and/or Volume
- Rest of the world Market Size and/or Volume
About Us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
